QCOM Vs AMD Stock: Which Is Best?

QCOM Vs AMD Stock: When it comes to investing in technology stocks, Qualcomm and Advanced Micro Devices are two names that always seem to top the list of Market News [Financhill] Smart Trading. Simplified. [Your Chance To Invest In The Green Energy Revolution!](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD0zMyZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekx6a3pRbHBZV2k4L1kzSmxZWFJwZG1WZmFXUTlNVEUxVwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Tin is the forgotten metal of the forthcoming electrification revolution. This company has a quality asset portfolio, is building a significant position, is in a fantastic location and has access to capital. They also just reported outstanding results. [Don't miss this one - click for more info and ADD THIS COMPANY TO YOUR WATCHLIST!](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD0zMyZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekx6a3pRbHBZV2k4L1kzSmxZWFJwZG1WZmFXUTlNVEUxVwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored QCOM Vs AMD Stock: Which Is Best? QCOM Vs AMD Stock: When it comes to investing in technology stocks, Qualcomm and Advanced Micro Devices are two names that always seem to top the list of potential buys. Indeed, both these companies have a strong track record of growth and innovation, and each is a leader in their respective sector. However, despite […] [Continue Reading >](~/AACAmgA~/RgRlqquUP0Q3aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9xY29tLXZzLWFtZC1zdG9ja1cDc3BjQgpjtd8myGPf2ccjUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAA~) [This U.S. Company Is Prepared To Slam The Breaks On Heart Disease](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NSZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwdzVUVGxUVnk4L1kzSmxZWFJwZG1WZmFXUTlNall5VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Heart disease is the leading cause of death for men, women, and most racial/ethnic groups in the United States. About 660,000 people in the U.S. die from heart disease every year that's 1 in every 4 deaths and on average 1 person every 40 seconds. One company above others could be well-positioned for this fight against heart disease. [Click Here For The Full Company Report.](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NSZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwdzVUVGxUVnk4L1kzSmxZWFJwZG1WZmFXUTlNall5VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored 5 Semiconductor Stocks to Buy in 2023 In 2020-21, global semiconductor market soared amid a mismatch between supply and demand. Going into 2023, several semiconductor giants have sold off considerably. Some of these stocks could be attractive for investors looking to profit from the continued global demand for chips. Here are five of the strongest semiconductor stocks to look at for […] [Continue Reading >](~/AACAmgA~/RgRlqquUP0RGaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9iZXN0LXNlbWljb25kdWN0b3Itc3RvY2tzLXRvLWJ1eVcDc3BjQgpjtd8myGPf2ccjUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAA~) [Could This Little-known Tech Company Disrupt 2 Massive Markets?](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NiZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwweERNalpMU0M4L1kzSmxZWFJwZG1WZmFXUTlNall6VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) The Brightfield Group, a cann-a-bis industry data research firm, reported sales of C-B-D products could hit $11Bn by 2027. A Zion Market Research study indicated the market size of global gynecology devices was worth $10.8Bn in 2021, estimated to pass $19.5Bn by 2028. Pair those together and it's easy to see why this Nasdaq tech company could be the next big thing. [Click for the full company report.](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NiZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwweERNalpMU0M4L1kzSmxZWFJwZG1WZmFXUTlNall6VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored 5 Fun Stocks To Own Fun Stocks To Own: Investing in companies that you have a positive emotional connection to can make the process of stock picking more enjoyable and engaging. This can be especially true if you’re a long-term investor, as it can help keep you motivated and attuned to the company’s success. Moreover, investing in a firm […] [Continue Reading >](~/AACAmgA~/RgRlqquUP0Q3aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9mdW4tc3RvY2tzLXRvLW93blcDc3BjQgpjtd8myGPf2ccjUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAA~) [Little-known Biotech Stock Announces Positive News](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OSZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwZFlOemRTVEM4L1kzSmxZWFJwZG1WZmFXUTlNakE1VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Many readers know that Biotech stocks offer tremendous breakout potential when positive news is announced from Phase 1, Phase 2 and Phase 3 trials. After positive news is announced, some of these little-known companies immediately become overnight sensations In particular, there is one Biotech stock that could be getting ready to announce Phase 3 results any day now. [Click Here for Free Stock Report](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02OSZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwZFlOemRTVEM4L1kzSmxZWFJwZG1WZmFXUTlNakE1VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored Is Walker & Dunlop Stock a Buy? Is Walker & Dunlop Stock a Buy? Real estate financing company Walker & Dunlop (NYSE:WD) saw its shares plummet by nearly 50 percent in 2022. The selloff was mostly due to lower earnings and margins caused by rapidly rising interest rates. Now that the stock is trading at about half its previous price, it […] [Continue Reading >](~/AACAmgA~/RgRlqquUP0RCaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9pcy13YWxrZXItZHVubG9wLXN0b2NrLWEtYnV5VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) [Could This Little-known Company Be Poised To Ride "Green Wave?"](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NCZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwdzRPRVkwT1M4L1kzSmxZWFJwZG1WZmFXUTlNall4VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) According to ResearchAndMarkets.com, the North American legal cann-a-bis market is expected to be valued at $42.3Bn by 2030. A reformed outlook on the legalization, acceptance, and adoption of cann-a-bis for medical use greatly contributes to its potential reach. One company, above others, could be very well positioned for this growth opportunity. [Click Here For The Full Company Report.](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD04NCZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwdzRPRVkwT1M4L1kzSmxZWFJwZG1WZmFXUTlNall4VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored Graham Stephan Net Worth Graham Stephan Net Worth: These days, there are so many millionaires that their accomplishments rarely make the news. Billionaires like Elon Musk, Warren Buffett, and Bill Gates get the most air time. However, there are exceptions, and Graham Stephan is one of them. Stephan is an exceptionally talented real estate agent, investor, and entrepreneur who […] [Continue Reading >](~/AACAmgA~/RgRlqquUP0Q-aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nL2ludmVzdGluZy9ncmFoYW0tc3RlcGhhbi1uZXQtd29ydGhXA3NwY0IKY7XfJshj39nHI1IbdHJpc3RyYW1iYWxkd2luODhAZ21haWwuY29tWAQAAAAA) [How to Own Tens of $Billions in Gold for Just US$1 Per Share](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02MCZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwWkhXRXhITVM4L1kzSmxZWFJwZG1WZmFXUTlNVGM0VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) A brand new gold bull market has arrived as nervous investors continue to flock to the safety of the yellow metal. Yet, the biggest gains won't be in gold...they'll be in select gold stocks with proven ounces in the ground. This soon-to-be-known gold company provides investors with exposure to over 30 million ounces of gold...worth tens of $Billions...at a ridiculously low US$1 per share. [More details here...](~/AACAmgA~/RgRlqquUP0R4aHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9hZD90eXBlPWltcyZpZD02MCZhZD1hSFIwY0hNNkx5OTNkM2N1YVcxemFtcHJNekE1TG1OdmJTOHlWRU5ZVURFekwwWkhXRXhITVM4L1kzSmxZWFJwZG1WZmFXUTlNVGM0VwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) Sponsored View this email [online](~/AACAmgA~/RgRlqquUP0QbaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS9ibG9nVwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~) if it doesn't display correctly. This newsletter is not financial advice. Please read our [Disclaimer](~/AACAmgA~/RgRlqquUP0QcaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS90ZXJtc1cDc3BjQgpjtd8myGPf2ccjUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAA~). To unsubscribe from Financhill, [click here](~/AACAmgA~/RgRlqquUP0RSaHR0cHM6Ly9maW5hbmNoaWxsLmNvbS91bnN1YnNjcmliZS9kYjI5MWQ3YjY4MTYxMDc5MWE5NjE0M2UyN2I3M2Q3NC01MDQ2NTkxOS04NjkxNVcDc3BjQgpjtd8myGPf2ccjUht0cmlzdHJhbWJhbGR3aW44OEBnbWFpbC5jb21YBAAAAAA~). PO Box 126 Catasauqua, PA 18032 Financhill is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of Financhill are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory. The sender of this email makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity's compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email. The content on any of Financhill websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: [Characteristics and Risks of Standardized Options](~/AACAmgA~/RgRlqquUP0RFaHR0cDovL3d3dy5vcHRpb25zY2xlYXJpbmcuY29tL2Fib3V0L3B1YmxpY2F0aW9ucy9jaGFyYWN0ZXItcmlza3MuanNwVwNzcGNCCmO13ybIY9_ZxyNSG3RyaXN0cmFtYmFsZHdpbjg4QGdtYWlsLmNvbVgEAAAAAA~~). The Financhill.com educational training program and software services are provided to improve financial understanding. The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing. Past performance is no guarantee of future performance. This product is for educational purposes only. Practical application of the products herein are at your own risk and Financhill.com, its partners, representatives and employees assume no responsibility or liability for any use or mis-use of the product. Please contact your financial advisor for specific financial advice tailored to your personal circumstances. Any trades shown are hypothetical example and do not represent actual trades. Actual results may differ. Nothing here in constitutes a recommendation respecting the particular security illustrated.